Research progress of inflammatory cytokines in the diagnosis and treatment of amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a multifactor, multiple genes disease which involving a variety of mechanisms. Neuroinflammatory response is one of the mechanisms. Many inflammatory cytokines are involved. It may be used in clinic as biomarkers and therapeutic targets. Many proteins encoded b...

Full description

Bibliographic Details
Main Author: LI Xiao-guang, YANG Lu, LIU Xu-dong, JIA Xin-miao, CHENG Yan-fei, CUI Li-ying
Format: Article
Language:zho
Published: Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2022-06-01
Series:Jichu yixue yu linchuang
Subjects:
Online Access:http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2022-42-6-964.pdf
_version_ 1827386942913773568
author LI Xiao-guang, YANG Lu, LIU Xu-dong, JIA Xin-miao, CHENG Yan-fei, CUI Li-ying
author_facet LI Xiao-guang, YANG Lu, LIU Xu-dong, JIA Xin-miao, CHENG Yan-fei, CUI Li-ying
author_sort LI Xiao-guang, YANG Lu, LIU Xu-dong, JIA Xin-miao, CHENG Yan-fei, CUI Li-ying
collection DOAJ
description Amyotrophic lateral sclerosis (ALS) is a multifactor, multiple genes disease which involving a variety of mechanisms. Neuroinflammatory response is one of the mechanisms. Many inflammatory cytokines are involved. It may be used in clinic as biomarkers and therapeutic targets. Many proteins encoded by mutant genes can damage the function of immune system, lead to immune dysfunction and drive the inflammatory response of central nervous system and peripheral immune system. There are many kinds of inflammatory cytokines with great diversification in their levels which influenced by the stage, type and comorbidity of the disease, the results are not consistent at present, and there is no single inflammatory cytokine identified as a specific marker. Inflammatory cytokines have a certain prospect as therapeutic monitoring markers and targets.
first_indexed 2024-03-08T15:53:50Z
format Article
id doaj.art-9c6fba49f8b14d9f896bb67cf1cee4ff
institution Directory Open Access Journal
issn 1001-6325
language zho
last_indexed 2024-03-08T15:53:50Z
publishDate 2022-06-01
publisher Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
record_format Article
series Jichu yixue yu linchuang
spelling doaj.art-9c6fba49f8b14d9f896bb67cf1cee4ff2024-01-09T02:51:51ZzhoInstitute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.Jichu yixue yu linchuang1001-63252022-06-0142696496810.16352/j.issn.1001-6325.2022.06.012Research progress of inflammatory cytokines in the diagnosis and treatment of amyotrophic lateral sclerosisLI Xiao-guang, YANG Lu, LIU Xu-dong, JIA Xin-miao, CHENG Yan-fei, CUI Li-ying01. Department of Neurology; 2. Centre for Medical Science Research,Peking Union Medical College Hospital, CAMS & PUMC, Beijing 100730; ;3. Department of Neurology, Linfen People's Hospital, the Seventh Clinical Medical College of Shanxi Medical University, Linfen 041000, ChinaAmyotrophic lateral sclerosis (ALS) is a multifactor, multiple genes disease which involving a variety of mechanisms. Neuroinflammatory response is one of the mechanisms. Many inflammatory cytokines are involved. It may be used in clinic as biomarkers and therapeutic targets. Many proteins encoded by mutant genes can damage the function of immune system, lead to immune dysfunction and drive the inflammatory response of central nervous system and peripheral immune system. There are many kinds of inflammatory cytokines with great diversification in their levels which influenced by the stage, type and comorbidity of the disease, the results are not consistent at present, and there is no single inflammatory cytokine identified as a specific marker. Inflammatory cytokines have a certain prospect as therapeutic monitoring markers and targets.http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2022-42-6-964.pdfamyotrophic lateral sclerosis|gene variant|inflammatory cytokines
spellingShingle LI Xiao-guang, YANG Lu, LIU Xu-dong, JIA Xin-miao, CHENG Yan-fei, CUI Li-ying
Research progress of inflammatory cytokines in the diagnosis and treatment of amyotrophic lateral sclerosis
Jichu yixue yu linchuang
amyotrophic lateral sclerosis|gene variant|inflammatory cytokines
title Research progress of inflammatory cytokines in the diagnosis and treatment of amyotrophic lateral sclerosis
title_full Research progress of inflammatory cytokines in the diagnosis and treatment of amyotrophic lateral sclerosis
title_fullStr Research progress of inflammatory cytokines in the diagnosis and treatment of amyotrophic lateral sclerosis
title_full_unstemmed Research progress of inflammatory cytokines in the diagnosis and treatment of amyotrophic lateral sclerosis
title_short Research progress of inflammatory cytokines in the diagnosis and treatment of amyotrophic lateral sclerosis
title_sort research progress of inflammatory cytokines in the diagnosis and treatment of amyotrophic lateral sclerosis
topic amyotrophic lateral sclerosis|gene variant|inflammatory cytokines
url http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2022-42-6-964.pdf
work_keys_str_mv AT lixiaoguangyangluliuxudongjiaxinmiaochengyanfeicuiliying researchprogressofinflammatorycytokinesinthediagnosisandtreatmentofamyotrophiclateralsclerosis